Skip to main content

Advertisement

Log in

Poorly differentiated chordoma with SMARCB1/INI1 loss: a distinct molecular entity with dismal prognosis

  • Correspondence
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Chavez JA, Din NU, Memon A et al (2014) Anaplastic chordoma with loss of INI1 and brachyury expression in a 2-year-old girl. Clin Neuropathol 33:418–420

    Article  PubMed  Google Scholar 

  2. Hoch BL, Nielsen GP, Liebsch NJ et al (2006) Base of skull chordomas in children and adolescents: a clinicopathologic study of 73 cases. Am J Surg Pathol 30:811–818

    Article  PubMed  Google Scholar 

  3. Johann P, Erkek S, Zapatka M et al (2016) Atypical teratoid/rhabdoid tumor (ATRT) comprises three epigenetic subgroups with distinct enhancer landscapes. Cancer Cell 29:379–393

    Article  CAS  PubMed  Google Scholar 

  4. Kazan S, Goksu E, Mihci E et al (2007) Primary atypical teratoid/rhabdoid tumor of the clival region. Case report. J Neurosurg 106:308–311

    PubMed  Google Scholar 

  5. Le LP, Nielsen GP, Rosenberg AE et al (2011) Recurrent chromosomal copy number alterations in sporadic chordomas. PLoS One 6:e18846

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Miettinen M, Wang Z, Lasota J et al (2015) Nuclear brachyury expression is consistent in chordoma, common in germ cell tumors and small cell carcinomas, and rare in other carcinomas and sarcomas: an immunohistochemical study of 5229 cases. Am J Surg Pathol 39:1305–1312

    Article  PubMed  Google Scholar 

  7. Mobley BC, McKenney JK, Bangs CD et al (2010) Loss of SMARCB1/INI1 expression in poorly differentiated chordomas. Acta Neuropathol 120:745–753

    Article  CAS  PubMed  Google Scholar 

  8. Sullivan LM, Folpe AL, Pawel BR et al (2013) Epithelioid sarcoma is associated with a high percentage of SMARCB1 deletions. Mod Pathol 26:385–392

    Article  CAS  PubMed  Google Scholar 

  9. Warmuth-Metz M, Bison B, Gerber NU et al (2013) Bone involvement in atypical teratoid/rhabdoid tumors of the CNS. AJNR Am J Neuroradiol 34:2039–2042

    Article  CAS  PubMed  Google Scholar 

  10. Yadav R, Sharma MC, Malgulwar PB et al (2014) Prognostic value of MIB-1, p53, epidermal growth factor receptor, and INI1 in childhood chordomas. Neuro Oncol 16:372–381

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Supported by IZKF Münster (Ha3/019/15) and KinderKrebsInitiative Buchholz Holm-Seppensen.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Martin Hasselblatt.

Additional information

M. Hasselblatt and C. Thomas contributed equally.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 652 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hasselblatt, M., Thomas, C., Hovestadt, V. et al. Poorly differentiated chordoma with SMARCB1/INI1 loss: a distinct molecular entity with dismal prognosis. Acta Neuropathol 132, 149–151 (2016). https://doi.org/10.1007/s00401-016-1574-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00401-016-1574-9

Keywords

Navigation